feed,title,long_url,short_url
Benzinga,Biosight Presents Updated New Clinical Data from Ongoing Phase 2b Study of Aspacytarabine (BST-236) at the 2020 ASH Annual Meeting,https://www.benzinga.com/pressreleases/20/12/g18670674/biosight-presents-updated-new-clinical-data-from-ongoing-phase-2b-study-of-aspacytarabine-bst-236-,https://j.mp/3oAoqzX
